Achalasia Treatment Market, Global Outlook and Forecast 2023-2029

Report ID: MMG194236 | Category: Medical Devices & Consumables | Pages: 63 | Format: PDF | Published Date: September 04,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Achalasia is a rare disorder that makes it difficult for food and liquid to pass from the swallowing tube connecting your mouth and stomach (esophagus) into your stomach. Achalasia occurs when nerves in the esophagus become damaged.
This report aims to provide a comprehensive presentation of the global market for Achalasia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Achalasia Treatment. This report contains market size and forecasts of Achalasia Treatment in global, including the following market information:
Global Achalasia Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Achalasia Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Calcium Channel Blockers (CCBs) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Achalasia Treatment include Bausch Health US LLC, Pfizer, Accordhealthcare, AdvaCare Pharma, Merz Therapeutics, Galderma, Zydus Pharmaceuticals (USA) Inc, Teva pharmaceutical industries ltd and Ohio State Medical Center, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Achalasia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Achalasia Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Achalasia Treatment Market Segment Percentages, by Type, 2022 (%)
    Calcium Channel Blockers (CCBs)
    Nifedipine
    Botulinum Toxin Injection
    Others
Global Achalasia Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Achalasia Treatment Market Segment Percentages, by Application, 2022 (%)
    Hospitals
    Retail Pharmacy
    Online Pharmacy
Global Achalasia Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Achalasia Treatment Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Achalasia Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Achalasia Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Bausch Health US LLC
    Pfizer
    Accordhealthcare
    AdvaCare Pharma
    Merz Therapeutics
    Galderma
    Zydus Pharmaceuticals (USA) Inc
    Teva pharmaceutical industries ltd
    Ohio State Medical Center
Outline of Major Chapters:
Chapter 1: Introduces the definition of Achalasia Treatment, market overview.
Chapter 2: Global Achalasia Treatment market size in revenue.
Chapter 3: Detailed analysis of Achalasia Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Achalasia Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Achalasia Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Achalasia Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Achalasia Treatment Overall Market Size
    2.1 Global Achalasia Treatment Market Size: 2022 VS 2029
    2.2 Global Achalasia Treatment Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Achalasia Treatment Players in Global Market
    3.2 Top Global Achalasia Treatment Companies Ranked by Revenue
    3.3 Global Achalasia Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Achalasia Treatment Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Achalasia Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Achalasia Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Achalasia Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Achalasia Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Achalasia Treatment Market Size Markets, 2022 & 2029
        4.1.2 Calcium Channel Blockers (CCBs)
        4.1.3 Nifedipine
        4.1.4 Botulinum Toxin Injection
        4.1.5 Others
    4.2 By Type - Global Achalasia Treatment Revenue & Forecasts
        4.2.1 By Type - Global Achalasia Treatment Revenue, 2018-2023
        4.2.2 By Type - Global Achalasia Treatment Revenue, 2024-2029
        4.2.3 By Type - Global Achalasia Treatment Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Achalasia Treatment Market Size, 2022 & 2029
        5.1.2 Hospitals
        5.1.3 Retail Pharmacy
        5.1.4 Online Pharmacy
    5.2 By Application - Global Achalasia Treatment Revenue & Forecasts
        5.2.1 By Application - Global Achalasia Treatment Revenue, 2018-2023
        5.2.2 By Application - Global Achalasia Treatment Revenue, 2024-2029
        5.2.3 By Application - Global Achalasia Treatment Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Achalasia Treatment Market Size, 2022 & 2029
    6.2 By Region - Global Achalasia Treatment Revenue & Forecasts
        6.2.1 By Region - Global Achalasia Treatment Revenue, 2018-2023
        6.2.2 By Region - Global Achalasia Treatment Revenue, 2024-2029
        6.2.3 By Region - Global Achalasia Treatment Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Achalasia Treatment Revenue, 2018-2029
        6.3.2 US Achalasia Treatment Market Size, 2018-2029
        6.3.3 Canada Achalasia Treatment Market Size, 2018-2029
        6.3.4 Mexico Achalasia Treatment Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Achalasia Treatment Revenue, 2018-2029
        6.4.2 Germany Achalasia Treatment Market Size, 2018-2029
        6.4.3 France Achalasia Treatment Market Size, 2018-2029
        6.4.4 U.K. Achalasia Treatment Market Size, 2018-2029
        6.4.5 Italy Achalasia Treatment Market Size, 2018-2029
        6.4.6 Russia Achalasia Treatment Market Size, 2018-2029
        6.4.7 Nordic Countries Achalasia Treatment Market Size, 2018-2029
        6.4.8 Benelux Achalasia Treatment Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Achalasia Treatment Revenue, 2018-2029
        6.5.2 China Achalasia Treatment Market Size, 2018-2029
        6.5.3 Japan Achalasia Treatment Market Size, 2018-2029
        6.5.4 South Korea Achalasia Treatment Market Size, 2018-2029
        6.5.5 Southeast Asia Achalasia Treatment Market Size, 2018-2029
        6.5.6 India Achalasia Treatment Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Achalasia Treatment Revenue, 2018-2029
        6.6.2 Brazil Achalasia Treatment Market Size, 2018-2029
        6.6.3 Argentina Achalasia Treatment Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Achalasia Treatment Revenue, 2018-2029
        6.7.2 Turkey Achalasia Treatment Market Size, 2018-2029
        6.7.3 Israel Achalasia Treatment Market Size, 2018-2029
        6.7.4 Saudi Arabia Achalasia Treatment Market Size, 2018-2029
        6.7.5 UAE Achalasia Treatment Market Size, 2018-2029
7 Achalasia Treatment Companies Profiles
    7.1 Bausch Health US LLC
        7.1.1 Bausch Health US LLC Company Summary
        7.1.2 Bausch Health US LLC Business Overview
        7.1.3 Bausch Health US LLC Achalasia Treatment Major Product Offerings
        7.1.4 Bausch Health US LLC Achalasia Treatment Revenue in Global Market (2018-2023)
        7.1.5 Bausch Health US LLC Key News & Latest Developments
    7.2 Pfizer
        7.2.1 Pfizer Company Summary
        7.2.2 Pfizer Business Overview
        7.2.3 Pfizer Achalasia Treatment Major Product Offerings
        7.2.4 Pfizer Achalasia Treatment Revenue in Global Market (2018-2023)
        7.2.5 Pfizer Key News & Latest Developments
    7.3 Accordhealthcare
        7.3.1 Accordhealthcare Company Summary
        7.3.2 Accordhealthcare Business Overview
        7.3.3 Accordhealthcare Achalasia Treatment Major Product Offerings
        7.3.4 Accordhealthcare Achalasia Treatment Revenue in Global Market (2018-2023)
        7.3.5 Accordhealthcare Key News & Latest Developments
    7.4 AdvaCare Pharma
        7.4.1 AdvaCare Pharma Company Summary
        7.4.2 AdvaCare Pharma Business Overview
        7.4.3 AdvaCare Pharma Achalasia Treatment Major Product Offerings
        7.4.4 AdvaCare Pharma Achalasia Treatment Revenue in Global Market (2018-2023)
        7.4.5 AdvaCare Pharma Key News & Latest Developments
    7.5 Merz Therapeutics
        7.5.1 Merz Therapeutics Company Summary
        7.5.2 Merz Therapeutics Business Overview
        7.5.3 Merz Therapeutics Achalasia Treatment Major Product Offerings
        7.5.4 Merz Therapeutics Achalasia Treatment Revenue in Global Market (2018-2023)
        7.5.5 Merz Therapeutics Key News & Latest Developments
    7.6 Galderma
        7.6.1 Galderma Company Summary
        7.6.2 Galderma Business Overview
        7.6.3 Galderma Achalasia Treatment Major Product Offerings
        7.6.4 Galderma Achalasia Treatment Revenue in Global Market (2018-2023)
        7.6.5 Galderma Key News & Latest Developments
    7.7 Zydus Pharmaceuticals (USA) Inc
        7.7.1 Zydus Pharmaceuticals (USA) Inc Company Summary
        7.7.2 Zydus Pharmaceuticals (USA) Inc Business Overview
        7.7.3 Zydus Pharmaceuticals (USA) Inc Achalasia Treatment Major Product Offerings
        7.7.4 Zydus Pharmaceuticals (USA) Inc Achalasia Treatment Revenue in Global Market (2018-2023)
        7.7.5 Zydus Pharmaceuticals (USA) Inc Key News & Latest Developments
    7.8 Teva pharmaceutical industries ltd
        7.8.1 Teva pharmaceutical industries ltd Company Summary
        7.8.2 Teva pharmaceutical industries ltd Business Overview
        7.8.3 Teva pharmaceutical industries ltd Achalasia Treatment Major Product Offerings
        7.8.4 Teva pharmaceutical industries ltd Achalasia Treatment Revenue in Global Market (2018-2023)
        7.8.5 Teva pharmaceutical industries ltd Key News & Latest Developments
    7.9 Ohio State Medical Center
        7.9.1 Ohio State Medical Center Company Summary
        7.9.2 Ohio State Medical Center Business Overview
        7.9.3 Ohio State Medical Center Achalasia Treatment Major Product Offerings
        7.9.4 Ohio State Medical Center Achalasia Treatment Revenue in Global Market (2018-2023)
        7.9.5 Ohio State Medical Center Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Achalasia Treatment Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?